Barchart recommends a ‘Strong Buy’ penny stock for investors looking to invest in AI drug development. This particular company shows promising potential in the field and is worth considering for those interested in this sector. With its innovative approach to drug development utilizing artificial intelligence, this penny stock could provide significant returns for investors in the future.